177 related articles for article (PubMed ID: 20414709)
1. A two-compartment effect site model describes the bispectral index after different rates of propofol infusion.
Björnsson MA; Norberg A; Kalman S; Karlsson MO; Simonsson US
J Pharmacokinet Pharmacodyn; 2010 Jun; 37(3):243-55. PubMed ID: 20414709
[TBL] [Abstract][Full Text] [Related]
2. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic and pharmacodynamic model of propofol externally validated in children.
Choi BM; Lee HG; Byon HJ; Lee SH; Lee EK; Kim HS; Noh GJ
J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):163-77. PubMed ID: 25724290
[TBL] [Abstract][Full Text] [Related]
4. Influence of administration rate on propofol plasma-effect site equilibration.
Struys MM; Coppens MJ; De Neve N; Mortier EP; Doufas AG; Van Bocxlaer JF; Shafer SL
Anesthesiology; 2007 Sep; 107(3):386-96. PubMed ID: 17721240
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery.
Wiczling P; Bienert A; Sobczyński P; Hartmann-Sobczyńska R; Bieda K; Marcinkowska A; Malatyńska M; Kaliszan R; Grześkowiak E
Pharmacol Rep; 2012; 64(1):113-22. PubMed ID: 22580527
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic-pharmacodynamic model of propofol in adolescents undergoing scoliosis surgery with intraoperative wake-up test: a study using Bispectral index and composite auditory evoked potentials as pharmacodynamic endpoints.
Blussé van Oud-Alblas HJ; Brill MJE; Peeters MYM; Tibboel D; Danhof M; Knibbe CAJ
BMC Anesthesiol; 2019 Jan; 19(1):15. PubMed ID: 30669968
[TBL] [Abstract][Full Text] [Related]
7. Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate.
Masui K; Kira M; Kazama T; Hagihira S; Mortier EP; Struys MM
Anesthesiology; 2009 Oct; 111(4):805-17. PubMed ID: 19741485
[TBL] [Abstract][Full Text] [Related]
8. Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia.
Vellinga R; Hannivoort LN; Introna M; Touw DJ; Absalom AR; Eleveld DJ; Struys MMRF
Br J Anaesth; 2021 Feb; 126(2):386-394. PubMed ID: 33317804
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents.
Chidambaran V; Venkatasubramanian R; Sadhasivam S; Esslinger H; Cox S; Diepstraten J; Fukuda T; Inge T; Knibbe CAJ; Vinks AA
Paediatr Anaesth; 2015 Sep; 25(9):911-923. PubMed ID: 25975390
[TBL] [Abstract][Full Text] [Related]
10. Age progression from vicenarians (20-29 year) to nonagenarians (90-99 year) among a population pharmacokinetic/pharmacodynamic (PopPk-PD) covariate analysis of propofol-bispectral index (BIS) electroencephalography.
Dahaba AA; Xiao Z; Zhu X; Dong H; Xiong L; Rehak P; Zelzer S; Wang K; Reibnegger G
J Pharmacokinet Pharmacodyn; 2020 Apr; 47(2):145-161. PubMed ID: 32100175
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation.
Eleveld DJ; Colin P; Absalom AR; Struys MMRF
Br J Anaesth; 2018 May; 120(5):942-959. PubMed ID: 29661412
[TBL] [Abstract][Full Text] [Related]
12. Effect-Site Target-Controlled Infusion in the Obese: Model Derivation and Performance Assessment.
Cortínez LI; Sepúlveda P; Rolle A; Cottin P; Guerrini A; Anderson BJ
Anesth Analg; 2018 Oct; 127(4):865-872. PubMed ID: 29401079
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of propofol in children undergoing different types of surgeries.
Bartkowska-Śniatkowska A; Bienert A; Wiczling P; Owczarek M; Rosada-Kurasińska J; Grześkowiak M; Matysiak J; Kokot ZJ; Kaliszan R; Grześkowiak E
Pharmacol Rep; 2014 Oct; 66(5):821-9. PubMed ID: 25149986
[TBL] [Abstract][Full Text] [Related]
14. Use of target controlled infusion to derive age and gender covariates for propofol clearance.
White M; Kenny GN; Schraag S
Clin Pharmacokinet; 2008; 47(2):119-27. PubMed ID: 18193918
[TBL] [Abstract][Full Text] [Related]
15. Induction speed is not a determinant of propofol pharmacodynamics.
Doufas AG; Bakhshandeh M; Bjorksten AR; Shafer SL; Sessler DI
Anesthesiology; 2004 Nov; 101(5):1112-21. PubMed ID: 15505446
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery.
Przybyłowski K; Tyczka J; Szczesny D; Bienert A; Wiczling P; Kut K; Plenzler E; Kaliszan R; Grześkowiak E
J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):111-22. PubMed ID: 25628234
[TBL] [Abstract][Full Text] [Related]
17. Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients.
Bienert A; Kusza K; Wawrzyniak K; Grześkowiak E; Kokot ZJ; Matysiak J; Grabowski T; Wolc A; Wiczling P; Regulski M
J Pharmacokinet Pharmacodyn; 2010 Jun; 37(3):289-304. PubMed ID: 20544262
[TBL] [Abstract][Full Text] [Related]
18. Comparison of plasma compartment versus two methods for effect compartment--controlled target-controlled infusion for propofol.
Struys MM; De Smet T; Depoorter B; Versichelen LF; Mortier EP; Dumortier FJ; Shafer SL; Rolly G
Anesthesiology; 2000 Feb; 92(2):399-406. PubMed ID: 10691226
[TBL] [Abstract][Full Text] [Related]
19. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I-III patients.
Bienert A; Wiczling P; Zaba C; Zaba Z; Wolc A; Marciniak R; Grześkowiak E; Kusza K
Arzneimittelforschung; 2011; 61(10):545-52. PubMed ID: 22164962
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions.
Wiczling P; Bieda K; Przybyłowski K; Hartmann-Sobczyńska R; Borsuk A; Matysiak J; Kokot ZJ; Sobczyński P; Grześkowiak E; Bienert A
Biopharm Drug Dispos; 2016 Jul; 37(5):252-63. PubMed ID: 26990035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
